Jupiter Neurosciences, Inc.
JUNS
$1.21
$0.032.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 2.24M | 1.52M | 860.70K | 492.70K | 536.40K |
| Gross Profit | -2.24M | -1.52M | -860.70K | -492.70K | -536.40K |
| SG&A Expenses | 5.31M | 4.24M | 3.19M | 2.59M | 1.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.56M | 5.75M | 4.05M | 3.08M | 2.16M |
| Operating Income | -7.56M | -5.75M | -4.05M | -3.08M | -2.16M |
| Income Before Tax | -7.60M | -5.90M | -3.33M | -2.44M | -1.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.60 | -5.90 | -3.33 | -2.44 | -1.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.60M | -5.90M | -3.33M | -2.44M | -1.34M |
| EBIT | -7.56M | -5.75M | -4.05M | -3.08M | -2.16M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.23 | -0.18 | -0.10 | -0.08 | -0.05 |
| Normalized Basic EPS | -0.14 | -0.11 | -0.08 | -0.07 | -0.05 |
| EPS Diluted | -0.23 | -0.18 | -0.10 | -0.08 | -0.05 |
| Normalized Diluted EPS | -0.14 | -0.11 | -0.08 | -0.07 | -0.05 |
| Average Basic Shares Outstanding | 131.97M | 128.99M | 123.35M | 116.77M | 111.56M |
| Average Diluted Shares Outstanding | 131.97M | 128.99M | 126.40M | 119.83M | 114.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |